Exchange: NASDAQ·Updated 07:47 PM EDT
GPCR logo

GPCR Structure Therapeutics Inc - ADR

$35.00
$0.10
(0.28%)
Today
Closed $35.00
$0.10
(0.29%)
After Hours
EarningsNov 5
Mkt Cap$2.5B
Vol1.55M

About GPCR

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
72

Bullish Sentiment

How do you feel about GPCR?

Advertisement|Remove ads.